Gov’t working to source Pfizer vaccine to inoculate high school children
The Guyana Government is exploring the possibility of sourcing the Pfizer-BioNTech COVID-19 vaccine in large quantities to inoculate the high school children.
The Minister of Education Priya Manickchand made this announcement on Monday during an interview on GlobeSpan24*7.
“There are no vaccines in the world as yet, although some trials have started for children under 12, so it’s not only here in Guyana. It’s across the world that we don’t have vaccines for kids under 12-years-old,” Minister Manickchand said.
She added, “We are sourcing and trying very hard to bring to the country the Pfizer vaccine, in large enough numbers to inoculate the high school population.”
The Education Minister explained that she has been using the opportunity while distributing the “Because We Care” cash grant to educate parents about the Pfizer vaccine.
The vaccine is currently authorized for ages 12 and older. Pfizer is now conducting clinical trials in children ages six months to 11 years, and the data should be ready to submit to the U.S. Food and Drug Administration in the next few months.
Research from 2000 plus sample size in 2020 had shown that the Pfizer-BioNTech vaccine is 100% effective in preventing the COVID-19 virus in children ages 12 through 15.
In late 2020, the U.S. Food and Drug Administration (FDA) allowed emergency use of the vaccine from age 16. This year the vaccine was given to children in the US from ages 12 to 15.
Meanwhile, President Dr. Irfaan Ali has promised to allocate all US Covid-19 vaccines to children if the country receives Pfizer-BioNTech.
In fact, the Head-of-State has announced that public schools will reopen in September 2021, after more than a year of closure due to the COVID-19 pandemic.
According to the Ministry of Health, of the 20,000 plus COVID-19 cases in Guyana, almost 1600 have been children under-14.
In May, US President Joe Biden announced that he would share 80M vaccines with the rest of the world. Last month he disclosed that of the first 25M tranches of doses to be sent overseas, 7M of those would go to Latin America and the Caribbean.
The White House had stated that the initial 25M doses would be shipped from existing federal stockpiles of Pfizer, Moderna, and Johnson and Johnson vaccines.